ARTNX
Price
$21.89
Change
-$0.08 (-0.36%)
Updated
Jul 13 closing price
Net Assets
97.43M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

ARTNX vs VSTSX

ARTNX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
ARTNX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTNX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. ARTNX (97.4M). VSTSX pays higher dividends than ARTNX: VSTSX (1.07) vs ARTNX (0.19). ARTNX was incepted earlier than VSTSX: ARTNX (6 years) vs VSTSX (10 years). ARTNX (2.27) is less costly to investors than VSTSX (0.01). ARTNX is a more actively managed with annual turnover of: 26.15 vs. VSTSX (3.00). ARTNX has a lower initial minimum investment than VSTSX: ARTNX (1000) vs VSTSX (5000000000). ARTNX annual gain was more profitable for investors over the last year : 26.15 vs. VSTSX (21.48). VSTSX return over 5 years is better than : 66.56 vs. ARTNX (58.05).
ARTNXVSTSXARTNX / VSTSX
Total Expense Ratio1.260.0112,600%
Annual Report Gross Expense Ratio2.270.0122,700%
Fund Existence6 years10 years-
Gain YTD14.30811.205128%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets97.4M2.3T0%
Annual Yield % from dividends0.191.0718%
Returns for 1 year26.1521.48122%
Returns for 3 years73.7567.06110%
Returns for 5 years58.0566.5687%
Returns for 10 yearsN/A239.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I